Patient driven methodology is the future of medical care and pharma business
Corona virus has shown that an exhaustive patient-driven methodology is the eventual fate of medical care and the pharma business.
Read more
Author: James R
Lymphoma treatment market is expected to grow at a CAGR of around 8.4% from 2020 to 2027
The global lymphoma treatment market is expected to grow at a CAGR of around 8.4% from 2020 to 2027 and
Read more
Research Report: overactive bladder treatment market is expected to grow at a CAGR of around 3.4% from 2020 to 2027
The global overactive bladder treatment market is expected to grow at a CAGR of around 3.4% from 2020 to 2027
Read more
Premas Biotech along with Oramed Pharmaceuticals develops oral Covid-19 vaccine
Premas Biotech, an Indian firm has worked together with American organization Oramed Pharmaceuticals Inc. what’s more, declared on March 19
Read more
U.S., European Union and other antitrust masters collaborate to weigh pharmaceutical mergers
U.S., European Union and other antitrust masters are collaborating to update how they weigh pharmaceutical mergers in a move that
Read more
Korea may face a shortage of around 3 million dosages
As developed nations stock up on Covid-19 vaccinations, Korea may face a shortage of around 3 million dosages to hit
Read more
QBiotics Group Limited joins TDM Growth Partners to accelerate drug development timelines
QBiotics Group Limited, a Brisbane (Australia) life sciences organization creating novel anticancer and wound healing drugs, is satisfied to report
Read moreSmart Microbial Cell Counter Market To Grow Healthcare Sector In 2021 to 2028
The report worldwide Smart Microbial Cell Counter Market which is in distributing stage gives an all encompassing outline of the
Read moreSmart Stethoscopes Market is Expected To Witness Faster Growth in Target Market Due To Developing Medical Device Standards 2021 – 2028
The report worldwide Smart Stethoscopes Market which is in distributing stage gives an all encompassing outline of the current
Read more
Amgen is purchasing Five Prime Therapeutics for about $1.9 billion
Amgen is purchasing Five Prime Therapeutics for about $1.9 billion to grow the reach its line of gastric cancer growth
Read more